Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
5 studies found for:    "Gastric lymphoma"
Show Display Options
Rank Status Study
1 Completed Antibiotic Therapy in Treating Patients With Low Grade Gastric Lymphoma
Condition: Lymphoma
Interventions: Dietary Supplement: bismuth subcitrate;   Drug: amoxicillin;   Drug: clarithromycin;   Drug: metronidazole hydrochloride;   Drug: omeprazole;   Drug: tetracycline hydrochloride
2 Unknown  Chlorambucil Compared With No Further Therapy Following Anti-Helicobacter Therapy in Treating Patients With Low-Grade Lymphoma of the Stomach
Condition: Gastric Cancer
Interventions: Drug: chlorambucil;   Drug: clarithromycin;   Drug: omeprazole;   Drug: tinidazole
3 Completed Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the Stomach
Condition: Lymphoma
Interventions: Drug: Amoxicillin;   Drug: Bismuth Subsalicylate;   Drug: Clarithromycin;   Drug: Metronidazole Hydrochloride;   Drug: Omeprazole;   Drug: Tetracycline Hydrochloride
4 Unknown  Helicobacter – Lymphoma – Radiation Part I: Eradication, Part II: Radiation
Conditions: Lymphoma;   Lymphoma, Non-Hodgkin
Interventions: Drug: proton pump inhibitor;   Drug: clarithromycin;   Drug: amoxicillin;   Drug: metronidazole;   Procedure: radiation therapy
5 Completed Phase II Study With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With Gastric Diffuse Large B-Cell Non-Hodgkin`s Lymphoma
Condition: Primary Gastric Diffuse-Large B-Cell Lymphoma
Intervention: Drug: Rituximab + CHOP chemotherapy

Indicates status has not been verified in more than two years